Fulviglen 250mg Injection

Fulviglen 250mg Injection is an estrogen blocker. It is used in the treatment of breast cancer in women who have gone through menopause. It works by adjusting the level of estrogen and slow down the growth of cancer cells.

Fulviglen 250mg Injection is given as an injection into the muscles under the supervision of a doctor. It should be taken as doctor your doctor's advice. The dose and how often you take it depends on what you are taking it for. Your doctor will decide how much you need to improve your symptoms. You should take this medicine for as long as it is prescribed for you.

The most common side effects of this medicine include injection site reaction, headache, vomiting, allergic reaction, and nausea. If these bother you, or appear serious, let your doctor know. There may be ways of reducing or preventing them.

Before taking this medicine, tell your doctor if you ever had kidney or liver disease or had bleeding disorder or had any blood clotting medicine. Your doctor should also know about all other medicines you are taking as many of these may make this medicine less effective or change the way it works. Tell your doctor if you are pregnant, planning pregnancy or breastfeeding.

• Breast cancer

Breast cancer
Fulviglen 250mg Injection relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipple or changes in the shape or texture of the breast. It works by altering the production of those hormones in the body that are essential for the growth and spread of breast cancer. It may also interact with other hormones or have a direct effect on the cancer to stop its growth. It is given as an injection by a doctor or nurse and should not be self- administered. Follow your doctor’s instructions carefully.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Celvestrant

• Headache
• Vomiting
• Weakness
• Allergic reaction
• Nausea
• Injection site reaction
• Urinary tract infection
• Diarrhea

Your doctor or nurse will give you this medicine. Kindly do not self administer.

Fulviglen 250mg Injection blocks the action of estrogen on breast cancer cells. This can lower or stop the growth of some breast cancer cells that need estrogen to grow.

• Fulviglen 250mg Injection is used for the treatment of hormone dependent breast cancer.
• It should only be taken by women who have undergone menopause and cannot become pregnant.
• It is given as a slow injection into the muscles (intramuscular) of your buttock.
• Inform your doctor if you have any bleeding disorder, kidney or liver disease or if you are receiving any medicines to prevent blood clots.
• Do not take Fulviglen 250mg Injection if you are pregnant or breastfeeding.

Masters SB. Hypothalmic & Pituitary Hormones. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 718.

Moy B, Lee RJ, Smith M. Natural Products in Cancer Chemotherapy: Hormones and Related Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. New York, New York: McGraw-Hill Medical; 2011. pp. 1759-60.

Drugs.com. Fulvestrant. [Accessed 03 Apr. 2019] (online) Available from:

Fulvestrant. Luton, Bedfordshire: AstraZeneca UK Limited; 2004 [revised 6 Sep 2018]. [Accessed 03 Apr. 2019] (online) Available from:

Fulvestrant. Cheshire, England: AstraZeneca UK Limited; 2002 [revised Jul. 2011]. [Accessed 03 Apr. 2019] (online) Available from:

Central Drugs Standard Control Organisation (CDSCO). [Accessed 04 Apr. 2019] (online) Available from: